SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pioneering trial tests cancer drug on patients with 'Double Trouble' autoimmune conditions
Disease control Recruiting nowThis study is testing the safety and effects of the immunotherapy drug nivolumab in people who have both advanced cancer and an autoimmune disease like lupus, rheumatoid arthritis, or Crohn's disease. It will enroll 300 adults to see if the drug can help control their cancer whil…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Light test could replace pinch exam for scleroderma skin
Diagnosis Recruiting nowThis study is testing a new, painless imaging device that uses light to measure skin thickening in people with scleroderma. Researchers want to see if this method is more accurate and consistent than the current standard, where doctors pinch the skin to assess thickness. The goal…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Boston University • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
Scientists hunt clues in rare Family-Linked scleroderma
Knowledge-focused Recruiting nowThis study aims to learn more about systemic scleroderma, a rare autoimmune disease, by studying families where more than one member has it. Researchers will recruit 20 adults with the disease who also have a close relative with it. By comparing these 'familial' cases, they hope …
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC